Bristol-Myers, Consumers Look To Centralize NJ Abilify Suits

By Rachel Graf (January 2, 2018, 1:58 PM EST) -- Bristol-Myers Squibb Co., Otsuka America Pharmaceutical Inc. and consumers of the companies' antipsychotic drug Abilify have urged a New Jersey state court to grant multi-county litigation status to at least 42 pending cases alleging that the treatment caused them to participate in compulsive activities such as gambling....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!